Cargando…

Clinical Application of the Heart Rate Deceleration Capacity Test to Predict Epirubicin-induced Cardiotoxicity

To investigate the clinical value of heart rate deceleration capacity (DC) in predicting the risk of epirubicin-induced cardiotoxicity. METHODS: The CK-MB and cTnI levels and DC values of 86 patients were examined before chemotherapy and again after 2 and 4 cycles of chemotherapy. Patients were divi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Yan-ying, Yang, Zhi-jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of Cardiovascular Pharmacology 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598070/ https://www.ncbi.nlm.nih.gov/pubmed/26080056 http://dx.doi.org/10.1097/FJC.0000000000000289

Ejemplares similares

The Predictive Value of 2D Myocardial Strain for Epirubicin-Induced Cardiotoxicity
por: Ben Abdallah, Ichrak, et al.
Publicado: (2020)

Changes of deceleration and acceleration capacity of heart rate in patients with acute hemispheric ischemic stroke
por: Xu, Yan-Hong, et al.
Publicado: (2016)

Deceleration capacity of heart rate variability as a predictor of sedation related hypotension
por: Tsai, Feng-Fang, et al.
Publicado: (2021)

Acceleration and Deceleration Capacity of Fetal Heart Rate in an In-Vivo Sheep Model
por: Rivolta, Massimo W., et al.
Publicado: (2014)

Heart rate acceleration and deceleration capacities associated with circadian blood pressure variation
por: Yan, Liyuan, et al.
Publicado: (2020)

Predictive values of heart rate variability, deceleration and acceleration capacity of heart rate in post‐infarction patients with LVEF ≥35%
por: Liu, Xiang, et al.
Publicado: (2020)

Deceleration and acceleration capacities of heart rate associated with heart failure with high discriminating performance
por: Hu, Wei, et al.
Publicado: (2016)

Autonomic function as indicated by heart rate deceleration capacity and deceleration runs in type 2 diabetes patients with or without essential hypertension
por: Wang, Xing-De, et al.
Publicado: (2018)

Preventing effect of astragalus polysaccharide on cardiotoxicity induced by chemotherapy of epirubicin: A pilot study
por: Li, Xiaofang, et al.
Publicado: (2022)

Predictive value of heart rate deceleration capacity on coronary artery lesion in acute phase of Kawasaki disease
por: Lu, Yaheng, et al.
Publicado: (2020)

Changes in deceleration capacity of heart rate and heart rate variability induced by ambient air pollution in individuals with coronary artery disease
por: Schneider, Alexandra, et al.
Publicado: (2010)

A refined method of quantifying deceleration capacity index for heart rate variability analysis
por: Liu, Hongyun, et al.
Publicado: (2018)

Delivery of epirubicin via slow infusion as a strategy to mitigate chemotherapy-induced cardiotoxicity
por: Yang, Fang, et al.
Publicado: (2017)

Low heart deceleration capacity imply higher atrial fibrillation-free rate after ablation
por: Chen, Zifan, et al.
Publicado: (2018)

Risk Prediction for Arrhythmias by Heart Rate Deceleration Runs in Patients with Chronic Obstructive Pulmonary Disease
por: Kong, Zhi-Bin, et al.
Publicado: (2020)

Deceleration capacity of heart rate predicts 1‐year mortality in patients undergoing transcatheter edge‐to‐edge mitral valve repair
por: Mizera, Lars, et al.
Publicado: (2023)

Blocking Store-Operated Ca(2+) Entry to Protect HL-1 Cardiomyocytes from Epirubicin-Induced Cardiotoxicity
por: Liu, Xian, et al.
Publicado: (2023)

Prognostic role of short-term heart rate variability and deceleration/acceleration capacities of heart rate in extensive-stage small cell lung cancer
por: Wu, Shuang, et al.
Publicado: (2023)

POLRMT as a Novel Susceptibility Gene for Cardiotoxicity in Epirubicin Treatment of Breast Cancer Patients
por: Velasco-Ruiz, Alejandro, et al.
Publicado: (2021)

Male Patients With Dilated Cardiomyopathy Exhibiting a Higher Heart Rate Acceleration Capacity or a Lower Deceleration Capacity Are at Higher Risk of Cardiac Death
por: Yang, Yichen, et al.
Publicado: (2018)

Cardioneuroablation for vasovagal syncope alters head-up tilt test response and reduces cardiac deceleration capacity
por: Cai, Simin, et al.
Publicado: (2023)

Influences of Age, Gender, and Circadian Rhythm on Deceleration Capacity in Subjects without Evident Heart Diseases
por: Zhao, Ruifu, et al.
Publicado: (2014)

Epirubicin
por: Cornish, J., et al.
Publicado: (1988)

Epirubicin-induced Kounis syndrome
por: Liang, Hui-zhu, et al.
Publicado: (2021)

Analysis of the electron beam line for the test of the RFQ decelerating system for the AD antiproton decelerator
por: Variola, Alessandro
Publicado: (1999)

Electron beam deceleration measurements using the decelerator test beam line in the Compact Linear Collider test facility
por: Lillestøl, R L, et al.
Publicado: (2014)

Preprocessing Unevenly Sampled RR Interval Signals to Enhance Estimation of Heart Rate Deceleration and Acceleration Capacities in Discriminating Chronic Heart Failure Patients from Healthy Controls
por: Cao, Ping, et al.
Publicado: (2020)

Low deceleration capacity is associated with higher stroke risk in patients with paroxysmal atrial fibrillation
por: Ding, Ying, et al.
Publicado: (2019)

Deceleration capacity is associated with acute respiratory distress syndrome in COVID-19
por: Mizera, Lars, et al.
Publicado: (2021)

Tests of the CPT Invariance at the Antiproton Decelerator of CERN
por: Horváth, D
Publicado: (2019)

A machine learning pipeline to classify foetal heart rate deceleration with optimal feature set
por: Das, Sahana, et al.
Publicado: (2023)

Correlation of UGT2B7 Polymorphism with Cardiotoxicity in Breast Cancer Patients Undergoing Epirubicin/Cyclophosphamide-Docetaxel Adjuvant Chemotherapy
por: Li, Hai, et al.
Publicado: (2019)

Clinical pharmacokinetics of epirubicin: the importance of liver biochemistry tests.
por: Twelves, C. J., et al.
Publicado: (1992)

Decelerated DNA methylation age predicts poor prognosis of breast cancer
por: Ren, Jun-Ting, et al.
Publicado: (2018)

The ELENA decelerator
por: Brice, Maximilien
Publicado: (2021)

The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
por: Liu, Lei, et al.
Publicado: (2017)

Differences in the Asymmetry of Beat-to-Beat Fetal Heart Rate Accelerations and Decelerations at Preterm and Term Active Labor
por: López-Justo, Carolina, et al.
Publicado: (2021)

Evolutionary Algorithm Optimization of Zeeman Deceleration: Is It Worthwhile for Longer Decelerators?
por: Toscano, Jutta, et al.
Publicado: (2019)

Patterned Illumination Techniques in Optogenetics: An Insight Into Decelerating Murine Hearts
por: Diaz-Maue, Laura, et al.
Publicado: (2022)

Assessment of left heart dysfunction to predict doxorubicin cardiotoxicity in children with lymphoma
por: Chen, Jiaqi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tjk383vl3s2gve7jq04fb3nvq8